In the present study, we aimed to evaluate the regulatory role of TLR2 in TB-triggered expression of VEGF and ZO-1 in PMCs and alteration in mesothelial permeability, as well as the clinical implication of soluble TLR2 (sTLR2) in TBPE. The gene discussed is VEGFA; the disease is tuberculosis.